Certified by Founder Lodge
MiRXES
Singapore - ND
INVESTOR
1 Disclosed Funding Rounds $4,500,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
MiRXES is a Singapore-headquartered biotechnology company whose mission is to save lives through early, actionable, and personalized diagnoses across the care continuum.
We are Asia-center
Med247
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Navier AI | $6,500,000 | (Dec 17, 2025)
Auxira Health | $7,800,000 | (Dec 17, 2025)
AIR Platforms | $6,100,000 | (Dec 17, 2025)
YSE Beauty | $15,000,000 | (Dec 17, 2025)
Mirelo AI | $41,000,000 | (Dec 17, 2025)
